Skip to main content

Currently Skimming:

4 Potential Strategies and Approaches for Private-Sector Engagement in the Sustainable Development Goals
Pages 41-58

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 41...
... Depending on P the specific approach, partners may include local government, academic insti tutions, multilateral organizations, nonprofit organizations, donor governments, and other businesses, among others (Aerts, Blander, Bruce, Clyde, Cohen, Cutillo, Goldberg, Lamporte, Merkel, Sienko, Tummon Kamphuis)
From page 42...
... From the Novartis Foundation, Ann Aerts presented the corporate foundation's approach to collective impact and commitment to creating a continuous cycle of evidence-based practice with the goal of increasing the effectiveness of its initiatives to reduce the global burden of noncommunicable diseases. Susanne Stormer of Novo Nordisk explained the company's triple b ­ ottom line approach, how it is integrated into its daily operations, and the related business case for engagement in the SDGs.
From page 43...
... The coalition applies each member company's knowledge, data, technology, and global networks to focus its efforts across five areas: road safety management, safer roads and mobility, safer vehicles, safer road users, and post-crash response. Part of those initial efforts included the launch of partnerships with the city governments of Shanghai, China, and Rio de Janeiro, Brazil, to develop locally focused initiatives that tackle road safety challenges.
From page 44...
... The Global Smart Drinking Goals will advance programs and initiatives that foster a culture of smart drinking through two principal efforts: changing behaviors through social norms and empowering consumers through choice. Public–private partnerships (PPPs)
From page 45...
... WDI's Healthcare Initiative works across the health care value chain to enable well-functioning markets, strengthen supply chain systems, and improve health care service delivery. Through its partnerships, WDI engages stakeholders out side of the university, including private-sector companies and governments, and stakeholders across disciplines within the campus.
From page 46...
... Cohen provided examples of BD's application of each of these methods to global partnerships that address specific health issues, including immunization (corporate philanthropy: Maternal and Neonatal Tetanus with UNICEF; shared value creation: Safe Immunization Devices with PATH) , lab system strengthening (CSR: Labs for Life; shared value creation: CD4 Testing with Clinton Foundation)
From page 47...
... Jhpiego does its work through partner ships with a broad spectrum of international, national, and community-level groups. Among these partners, private-sector companies are an important stake­ holder group and Lamporte and Merkel shared how Jhpiego partners with com panies through different approaches to partnerships, including corporate philan thropy, corporate social responsibility, and shared value creation.
From page 48...
... The program is developing use cases that address chronic condition management, community wellness, and nursing home care that can be shared globally. Beyond the United Kingdom, the company is working in India and Africa to apply ICT to support initiatives to tackle climate change, poverty, inequality, and health.
From page 49...
... NOVARTIS FOUNDATION Ann Aerts, Novartis Foundation Ann Aerts of the Novartis Foundation presented examples of the foundation's collective impact model for promoting innovative health care delivery for noncommunicable diseases (NCDs)
From page 50...
... Using these elements, the foundation has partnered with FHI 360, Ghana Health Service, London School of Hygiene & Tropical Medicine, VOTO Mobile, and numerous local partners to address hypertension care in Ghana's low-income urban settings. Aerts stated that the program is a PPP through which partners share lessons learned and cross-fertilize to tackle hypertension in a holistic way.
From page 51...
... One of the benefits to such partnerships can be the corporate expertise that Novartis provides. For example, when partnerships require strengthening in human resources, or finance management, the foundation invites Novartis employees to mentor local partners onsite.
From page 52...
... The company defines financial responsibility as long-term profitability while earning and spending capital in a way that contributes to society; social responsibility is defined as enabling people, including patients, employees, and communities, to thrive; and environmental responsibility is minimizing negative impacts on the environment. Novo Nordisk's approach is premised on the belief that a healthy environment, society, and economy are fundamental to long-term business success.
From page 53...
... Allison Tummon Kamphuis of P&G presented the company's approach to the SDG agenda. P&G, established nearly 180 years ago as a local business in Cincinnati, has found that its long-standing approach to delivering products and services aligns with the principles of the SDGs, including promotion of good governance, ethical responsibility and behavior, transparency, health improvement, and environmental protection among others.
From page 54...
... BOX 4-5 Spotlight Discussion with Andrew Jack, Financial Times In a spotlight discussion, Andrew Jack of the Financial Times discussed the role of the media in disseminating and shaping global health agendas and in facili tating the development of PPPs for health progress. Through his articles, Jack has played a role in shaping global health policies by bringing health topics to the fore front; if an article reaches an advantageous audience, the message can have an effect in shifting the global health landscape.
From page 55...
... These nongrant financing mechanisms include repayable grants and debt convertible to equity. Singer emphasized that these mechanisms are not subsidizing private-sector investments but rather are public–private combined financing mechanisms that facilitate the ability of multinational companies to invest in global health innovations by cushioning the risks and decreases barriers to invest.
From page 56...
... GHIF raised $108 million for investments over a 10-year period, with two option years, to identify these investment opportunities and demonstrate the potential for sustainable investments in global health. Reflecting on the process of taking global health innovations to scale and the models employed by GCC, CHAI, and GHIF to spur marketbased solutions, Singer suggested the financing of innovations in health can be thought of as a relay race: the first leg of the relay race is supporting the development of innovation, often through development agencies and private philanthropy; the second leg is handing off the innovation to companies that can serve as scaling platforms; and ultimately the third and final leg is handing off the innovation to domestic governments whose significant financial involvement will allow the innovation to scale.
From page 57...
... Bagsværd, Denmark: Novo Nordisk. http://www.novonordisk.com/content/dam/Denmark/HQ/Sustainibility/ documents/blueprint/Partnering-to-innovate-diabetescare-Algeria-BCP-2016-UK.pdf (accessed April 20, 2017)


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.